2-azaspiro[3.4]octane derivatives as M4 agonists

Provided herein are compounds according to Formula (I)or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonis...

Full description

Saved in:
Bibliographic Details
Main Authors Qian, Ming, Thomson, Christopher G, Calhoun, Amy, Hall, Edward Charles, Labbe-Giguere, Nancy, Chen, Xin, Shultz, Michael David, Neef, James, Palacios, Daniel Steven, Yang, Fan, Wang, Kate Yaping, Jendza, Keith, Gardinier, Kevin Matthew
Format Patent
LanguageEnglish
Published 22.10.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are compounds according to Formula (I)or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
Bibliography:Application Number: US202218062356